KIGALI, RWANDA — ViiV Healthcare, the HIV-focused biotech that's majority-owned by GSK, said it's expanding its voluntary licensing agreement with the Medicines Patent Pool and three generic manufacturers to include its long-acting HIV treatment. ...
↧
